RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
5.39
-0.22 (-3.92%)
Jul 21, 2026, 1:37 PM EDT - Market open
RxSight Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -46.64 | -38.94 | -27.46 | -48.61 | -66.76 | -48.69 |
Depreciation & Amortization | 3.32 | 3.27 | 3.58 | 4.08 | 4.02 | 3.99 |
Stock-Based Compensation | 32.42 | 31.61 | 24.64 | 15.75 | 11.4 | 7.58 |
Other Adjustments | 1.97 | -7.01 | -5.68 | -6.3 | -0.1 | -4.91 |
Change in Receivables | 8.52 | 6.66 | -9.8 | -9.33 | -6.09 | -2 |
Changes in Inventories | -13.26 | -11.48 | -4.99 | -2.75 | -7.56 | -2.11 |
Changes in Accounts Payable | -0.02 | 0.63 | 0.95 | 1.25 | 0.64 | 0.56 |
Changes in Accrued Expenses | 3.03 | -1.88 | 5.87 | 2.31 | 4.81 | 3.68 |
Changes in Other Operating Activities | 1.05 | 1.18 | -1.18 | -0.4 | 0.79 | -2.81 |
Operating Cash Flow | -17.57 | -15.51 | -16.95 | -41.59 | -58.85 | -44.71 |
Capital Expenditures | -4.01 | -3.83 | -5.44 | -4.81 | -2.39 | -1.94 |
Purchases of Investments | -301.1 | -239.28 | -336.87 | -272.32 | -212.66 | -159.97 |
Proceeds from Sale of Investments | 310 | 260 | 243 | 255 | 255 | 80 |
Investing Cash Flow | -9 | 16.89 | -99.31 | -22.13 | 39.95 | -81.91 |
Long-Term Debt Issued | - | - | - | 20 | - | 15 |
Long-Term Debt Repaid | - | - | - | -60 | - | - |
Net Long-Term Debt Issued (Repaid) | - | - | - | -40 | - | 15 |
Issuance of Common Stock | 3.4 | 112.05 | 74.87 | 51.91 | 7.83 | 121.14 |
Repurchase of Common Stock | -1.12 | -2.06 | -4.77 | -1.42 | -0.64 | - |
Net Common Stock Issued (Repurchased) | 2.28 | 109.99 | 70.1 | 50.48 | 7.19 | 121.14 |
Issuance of Preferred Stock | - | - | - | - | - | 0.79 |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | - | 0.79 |
Other Financing Activities | -0.02 | -0.03 | -0.83 | -3.01 | -0.85 | 0.42 |
Financing Cash Flow | 2.26 | 1.86 | 123.32 | 61.52 | 6.33 | 137.34 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | 0 | -0.01 | 0.01 | -0.01 | -0.01 |
Net Cash Flow | -10.72 | 3.24 | 7.05 | -2.19 | -12.58 | 10.72 |
Free Cash Flow | -21.58 | -19.34 | -22.39 | -46.41 | -61.24 | -46.65 |
FCF Margin | -16.93% | -14.38% | -16.00% | -52.10% | -124.97% | -206.47% |
Free Cash Flow Per Share | -0.53 | -0.47 | -0.58 | -1.35 | -2.21 | -3.42 |
Levered Free Cash Flow | -56.53 | -51.06 | -28.68 | -88.93 | -66.45 | -32.32 |
Unlevered Free Cash Flow | -65.3 | -60.38 | -38.15 | -50.42 | -63.02 | -51.43 |